What Will JAK Inhibitor Safety Jitters Mean For Drug Sales?

FDA Delays Decisions On Pfizer, Lilly/Incyte Drugs

 
• By Alaric DeArment
Slow-Down Sign_147945794_1200.jpg
The FDA delayed decisions on two JAK inhibitors from Pfizer and one from Lilly, likely because of safety concerns about the class. • Source: Shutterstock

More from Business

More from Scrip